Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DXC Technology CoDXC · Entity 4594 | Director | August 20, 2021 | August 24, 2021 |
| Empery Digital Inc.VLCN · Entity 21 | Director | July 17, 2025 | July 21, 2025 |
| KIMBERLY CLARK CORPKMB · Entity 3103 | Director | January 03, 2022 | January 05, 2022 |
| PFIZER INCPFE · Entity 2863 | Director · Executive Chairman | March 04, 2019 | March 06, 2019 |
| Population Health Investment Co., Inc.PHIC · Entity 136038 | Director · Executive Chairman | November 17, 2020 | November 17, 2020 |
| Viatris IncVTRS · Entity 3277 | Director | March 21, 2022 | March 23, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DXC Technology Co
Report date August 20, 2021 · Filed August 24, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 48,800 |
Reported balance
After 2021-08-20 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2021-08-20 · Grant · Acquired 12,700 · Balance 48,800 F1: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock. The RSUs will vest on the earlier of (i) one year from the grant date, or (ii) at the next annual meeting of stockholders. The RSUs will settle on the vesting date or, if the director has elected to defer settlement, on the date or event elected by the director. F2: Amount reported includes unvested RSUs. |
Filing footnotes · ownership attribution and instrument terms
F1: Award of restricted stock units (RSUs). Each RSU entitles the reporting person to receive one share of common stock. The RSUs will vest on the earlier of (i) one year from the grant date, or (ii) at the next annual meeting of stockholders. The RSUs will settle on the vesting date or, if the director has elected to defer settlement, on the date or event elected by the director.
F2: Amount reported includes unvested RSUs.
Empery Digital Inc.
Report date July 17, 2025 · Filed July 21, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 30,000 |
Reported balance
After 2025-07-21 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2025-07-21 · Grant · Acquired 30,000 · Balance 30,000 F1: The shares of common stock were purchased by the Reporting Person in the Issuer's recently announced private placement with certain accredited and institutional investors, which closed on July 21, 2025. F2: The shares of common stock were purchased by the Ian Charles Read Revocable Trust the ("Trust"). The Reporting Person is the trustee of the trust and may be deemed to have sole voting and dispositive power over the shares held by the Trust. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein. |
| Stock options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $10.00 · Expires 2035-07-17 | Direct | 298,802 |
Reported balance
After 2025-07-17 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2025-07-17 · Grant · Acquired 298,802 · Balance 298,802 F3: The stock options vest based upon the daily volume weighted average price ("VWAP") of the Issuer's common stock, vesting as to 20% of the underlying shares of common stock upon the VWAP reaching $10 and then in incremental 20% installments until becoming fully vested upon a VWAP of $30. All vesting is subject to the approval by the Issuer's stockholder of a new stock option plan. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares of common stock were purchased by the Reporting Person in the Issuer's recently announced private placement with certain accredited and institutional investors, which closed on July 21, 2025.
F2: The shares of common stock were purchased by the Ian Charles Read Revocable Trust the ("Trust"). The Reporting Person is the trustee of the trust and may be deemed to have sole voting and dispositive power over the shares held by the Trust. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
F3: The stock options vest based upon the daily volume weighted average price ("VWAP") of the Issuer's common stock, vesting as to 20% of the underlying shares of common stock upon the VWAP reaching $10 and then in incremental 20% installments until becoming fully vested upon a VWAP of $30. All vesting is subject to the approval by the Issuer's stockholder of a new stock option plan.
KIMBERLY CLARK CORP
Report date January 03, 2022 · Filed January 05, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Share UnitsSEC Table II · derivative / convertible security | Direct | 37,206 |
Reported balance
After 2022-01-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-01-03 · Grant · Acquired 1,299 · Balance 37,206 F1: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F2: Includes restricted share units which were accrued based on dividends paid on the Corporation's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors.
F2: Includes restricted share units which were accrued based on dividends paid on the Corporation's common stock.
PFIZER INC
Report date March 04, 2019 · Filed March 06, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,109,202 |
Ending reported balance
After 2019-03-04 transaction · row 26
26 source rows · reconciled sequenceRow 1 · 2019-03-04 · Sale · Disposed 3,722 · Balance 1,635,558 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 2 · 2019-03-04 · Sale · Disposed 4,258 · Balance 1,631,300 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 3 · 2019-03-04 · Sale · Disposed 4,392 · Balance 1,626,908 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 4 · 2019-03-04 · Sale · Disposed 4,489 · Balance 1,622,419 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 5 · 2019-03-04 · Sale · Disposed 5,812 · Balance 1,616,607 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 6 · 2019-03-04 · Sale · Disposed 6,284 · Balance 1,610,323 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 7 · 2019-03-04 · Sale · Disposed 6,960 · Balance 1,603,363 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 8 · 2019-03-04 · Sale · Disposed 7,584 · Balance 1,595,779 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 9 · 2019-03-04 · Sale · Disposed 8,427 · Balance 1,587,352 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 10 · 2019-03-04 · Sale · Disposed 10,725 · Balance 1,576,627 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 11 · 2019-03-04 · Sale · Disposed 11,804 · Balance 1,564,823 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 12 · 2019-03-04 · Sale · Disposed 11,908 · Balance 1,552,915 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 13 · 2019-03-04 · Sale · Disposed 12,457 · Balance 1,540,458 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 14 · 2019-03-04 · Sale · Disposed 12,623 · Balance 1,527,835 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 15 · 2019-03-04 · Sale · Disposed 12,787 · Balance 1,515,048 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 16 · 2019-03-04 · Sale · Disposed 12,971 · Balance 1,502,077 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 17 · 2019-03-04 · Sale · Disposed 13,275 · Balance 1,488,802 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 18 · 2019-03-04 · Sale · Disposed 14,739 · Balance 1,474,063 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 19 · 2019-03-04 · Sale · Disposed 16,537 · Balance 1,457,526 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 20 · 2019-03-04 · Sale · Disposed 21,624 · Balance 1,435,902 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 21 · 2019-03-04 · Sale · Disposed 28,599 · Balance 1,407,303 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 22 · 2019-03-04 · Sale · Disposed 34,216 · Balance 1,373,087 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 23 · 2019-03-04 · Sale · Disposed 52,878 · Balance 1,320,209 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 24 · 2019-03-04 · Sale · Disposed 69,362 · Balance 1,250,847 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 25 · 2019-03-04 · Sale · Disposed 69,433 · Balance 1,181,414 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Row 26 · 2019-03-04 · Sale · Disposed 72,212 · Balance 1,109,202 F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. |
| Common StockSEC Table I · non-derivative | IndirectBy Rule 16b-3 Plan | 11,442 |
Reported balance
Holding disclosure · report date 2019-03-04 · row 27
Holding and transaction disclosures are not merged.
1 source rowRow 27 · Balance 11,442 |
Filing footnotes · ownership attribution and instrument terms
F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018.
Population Health Investment Co., Inc.
Report date November 17, 2020 · Filed November 17, 2020
This filing explicitly reported no securities owned.
Viatris Inc
Report date March 21, 2022 · Filed March 23, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 14,497 |
Reported balance
After 2022-03-21 transaction · row 1
1 source rowRow 1 · 2022-03-21 · Exercise / conversion · Acquired 166 · Balance 14,497 F1: Fractional shares have been rounded up in connection with the settlement described in footnote 2 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan. |
| Dividend Equivalent UnitsSEC Table II · derivative / convertible security | Direct | 165.5224 |
Reported balance
After 2022-03-21 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2022-03-21 · Grant · Acquired 165.5224 · Balance 165.5224 F2: Represents dividend equivalent units (DEUs) that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested. |
| Dividend Equivalent UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2022-03-21 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-03-21 · Exercise / conversion · Disposed 165.5224 · Balance 0 F2: Represents dividend equivalent units (DEUs) that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested. |
Filing footnotes · ownership attribution and instrument terms
F1: Fractional shares have been rounded up in connection with the settlement described in footnote 2 pursuant to the terms of the restricted stock unit (RSU) award agreement under the Viatris Inc. 2020 Stock Incentive Plan.
F2: Represents dividend equivalent units (DEUs) that accrued with respect to RSUs previously granted on March 2, 2021. The DEUs vested upon accrual as the underlying RSUs had previously vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 04, 2019 Filed Mar 6, 2019 21:03 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 200 | $43.23 | $8,646.00 |
DisclosureSEC source: 0001225208-19-004781 · doc4.xml · nonDerivative · entry 2 READ IAN C · CIK 0001372915 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,689,768 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 21:03 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 100 | $43.11 | $4,311.00 |
DisclosureSEC source: 0001225208-19-004781 · doc4.xml · nonDerivative · entry 1 READ IAN C · CIK 0001372915 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,689,968 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 21:03 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 72,212 | $43.00 | $3,105,116.00 |
DisclosureSEC source: 0001225208-19-004782 · doc4.xml · nonDerivative · entry 26 READ IAN C · CIK 0001372915 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,109,202 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 21:03 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 69,433 | $43.02 | $2,987,007.66 |
DisclosureSEC source: 0001225208-19-004782 · doc4.xml · nonDerivative · entry 25 READ IAN C · CIK 0001372915 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,181,414 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 21:03 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 69,362 | $43.03 | $2,984,646.86 |
DisclosureSEC source: 0001225208-19-004782 · doc4.xml · nonDerivative · entry 24 READ IAN C · CIK 0001372915 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,250,847 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 21:03 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 52,878 | $43.01 | $2,274,282.78 |
DisclosureSEC source: 0001225208-19-004782 · doc4.xml · nonDerivative · entry 23 READ IAN C · CIK 0001372915 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,320,209 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 21:03 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 34,216 | $43.04 | $1,472,656.64 |
DisclosureSEC source: 0001225208-19-004782 · doc4.xml · nonDerivative · entry 22 READ IAN C · CIK 0001372915 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,373,087 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 21:03 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 28,599 | $43.05 | $1,231,186.95 |
DisclosureSEC source: 0001225208-19-004782 · doc4.xml · nonDerivative · entry 21 READ IAN C · CIK 0001372915 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,407,303 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 21:03 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 21,624 | $43.50 | $940,644.00 |
DisclosureSEC source: 0001225208-19-004782 · doc4.xml · nonDerivative · entry 20 READ IAN C · CIK 0001372915 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,435,902 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 21:03 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 16,537 | $43.49 | $719,194.13 |
DisclosureSEC source: 0001225208-19-004782 · doc4.xml · nonDerivative · entry 19 READ IAN C · CIK 0001372915 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,457,526 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 21:03 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 14,739 | $43.06 | $634,661.34 |
DisclosureSEC source: 0001225208-19-004782 · doc4.xml · nonDerivative · entry 18 READ IAN C · CIK 0001372915 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,474,063 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 21:03 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 13,275 | $43.53 | $577,860.75 |
DisclosureSEC source: 0001225208-19-004782 · doc4.xml · nonDerivative · entry 17 READ IAN C · CIK 0001372915 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,488,802 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 21:03 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 12,971 | $43.48 | $563,979.08 |
DisclosureSEC source: 0001225208-19-004782 · doc4.xml · nonDerivative · entry 16 READ IAN C · CIK 0001372915 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,502,077 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 21:03 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 12,787 | $43.45 | $555,595.15 |
DisclosureSEC source: 0001225208-19-004782 · doc4.xml · nonDerivative · entry 15 READ IAN C · CIK 0001372915 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,515,048 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 21:03 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 12,623 | $43.47 | $548,721.81 |
DisclosureSEC source: 0001225208-19-004782 · doc4.xml · nonDerivative · entry 14 READ IAN C · CIK 0001372915 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,527,835 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 21:03 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 12,457 | $43.51 | $542,004.07 |
DisclosureSEC source: 0001225208-19-004782 · doc4.xml · nonDerivative · entry 13 READ IAN C · CIK 0001372915 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,540,458 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 21:03 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 11,908 | $43.42 | $517,045.36 |
DisclosureSEC source: 0001225208-19-004782 · doc4.xml · nonDerivative · entry 12 READ IAN C · CIK 0001372915 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,552,915 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 21:03 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 11,804 | $43.07 | $508,398.28 |
DisclosureSEC source: 0001225208-19-004782 · doc4.xml · nonDerivative · entry 11 READ IAN C · CIK 0001372915 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,564,823 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 21:03 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 10,725 | $43.52 | $466,752.00 |
DisclosureSEC source: 0001225208-19-004782 · doc4.xml · nonDerivative · entry 10 READ IAN C · CIK 0001372915 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,576,627 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 21:03 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 8,427 | $43.37 | $365,478.99 |
DisclosureSEC source: 0001225208-19-004782 · doc4.xml · nonDerivative · entry 9 READ IAN C · CIK 0001372915 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,587,352 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 21:03 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 7,584 | $43.36 | $328,842.24 |
DisclosureSEC source: 0001225208-19-004782 · doc4.xml · nonDerivative · entry 8 READ IAN C · CIK 0001372915 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,595,779 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 21:03 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 6,960 | $43.44 | $302,342.40 |
DisclosureSEC source: 0001225208-19-004782 · doc4.xml · nonDerivative · entry 7 READ IAN C · CIK 0001372915 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,603,363 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 21:03 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 6,284 | $43.54 | $273,605.36 |
DisclosureSEC source: 0001225208-19-004782 · doc4.xml · nonDerivative · entry 6 READ IAN C · CIK 0001372915 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,610,323 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 21:03 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 5,812 | $43.24 | $251,310.88 |
DisclosureSEC source: 0001225208-19-004782 · doc4.xml · nonDerivative · entry 5 READ IAN C · CIK 0001372915 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,616,607 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 21:03 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 4,489 | $43.34 | $194,553.26 |
DisclosureSEC source: 0001225208-19-004782 · doc4.xml · nonDerivative · entry 4 READ IAN C · CIK 0001372915 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,622,419 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 21:03 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 4,392 | $43.43 | $190,744.56 |
DisclosureSEC source: 0001225208-19-004782 · doc4.xml · nonDerivative · entry 3 READ IAN C · CIK 0001372915 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,626,908 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 21:03 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 4,258 | $43.40 | $184,797.20 |
DisclosureSEC source: 0001225208-19-004782 · doc4.xml · nonDerivative · entry 2 READ IAN C · CIK 0001372915 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,631,300 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Read SEC document |
| March 04, 2019 Filed Mar 6, 2019 21:03 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 3,722 | $43.33 | $161,274.26 |
DisclosureSEC source: 0001225208-19-004782 · doc4.xml · nonDerivative · entry 1 READ IAN C · CIK 0001372915 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,635,558 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2018. Read SEC document |
| February 28, 2019 Filed Mar 2, 2019 00:47 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 202,819 | $0.00 Strike: $43.35 | $0.00 |
DisclosureSEC source: 0001225208-19-004218 · doc4.xml · derivative · entry 6 READ IAN C · CIK 0001372915 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,819 Underlying: Common Stock · 202,819 shares Expires 2026-02-28 F5 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. F5 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the seventh anniversary of the date of grant. Read SEC document |
| February 28, 2019 Filed Mar 2, 2019 00:47 UTC | PFIZER INC PFE · Entity 2863 | GrantStock Appreciation Rights · Derivative | 240,670 | $0.00 Strike: $43.35 | $0.00 |
DisclosureSEC source: 0001225208-19-004218 · doc4.xml · derivative · entry 5 READ IAN C · CIK 0001372915 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 240,670 Underlying: Common Stock · 240,670 shares Expires 2024-02-28 F4 · derivative.exercise_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. F4 · derivative.expiration_date: The stock appreciation rights, which are subject to certain vesting requirements, will be settled in shares of Pfizer common stock on the fifth anniversary of the date of grant. Read SEC document |
| February 27, 2019 Filed Mar 2, 2019 00:47 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 153,644 | $42.93 | $6,595,936.92 |
DisclosureSEC source: 0001225208-19-004218 · doc4.xml · nonDerivative · entry 3 READ IAN C · CIK 0001372915 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,690,068 F3 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 27, 2019 Filed Mar 2, 2019 00:47 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 90,352 | $42.93 | $3,878,811.36 |
DisclosureSEC source: 0001225208-19-004218 · doc4.xml · nonDerivative · entry 2 READ IAN C · CIK 0001372915 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,843,712 F2 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the settlement of stock units from previously exercised stock appreciation rights (including dividend equivalents thereon). Read SEC document |
| February 27, 2019 Filed Mar 2, 2019 00:47 UTC | PFIZER INC PFE · Entity 2863 | GrantCommon Stock | 347,327 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-004218 · doc4.xml · nonDerivative · entry 1 READ IAN C · CIK 0001372915 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,934,064 F1 · shares: The reported transaction constitutes the earn-out of Performance Share Awards (including dividend equivalents thereon). Read SEC document |
| February 23, 2019 Filed Feb 27, 2019 01:17 UTC | PFIZER INC PFE · Entity 2863 | Tax withholdingCommon Stock | 193,170 | $42.96 | $8,298,583.20 |
DisclosureSEC source: 0001225208-19-003786 · doc4.xml · nonDerivative · entry 1 READ IAN C · CIK 0001372915 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,586,737 F1 · shares: The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the settlement of stock units from previously exercised stock appreciation rights (including dividend equivalents thereon). F2 · price: Price is the closing price of Pfizer common stock on February 22, 2019 Read SEC document |
| January 02, 2019 Filed Jan 3, 2019 21:15 UTC | KIMBERLY CLARK CORP KMB · Entity 3103 | GrantRestricted Share Units · Derivative | 1,879 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001225208-19-000363 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,896.7081 Underlying: Common Stock · 1,879 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · derivative.exercise_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · derivative.expiration_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. Read SEC document |
| November 02, 2018 Filed Nov 6, 2018 20:46 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 539,305 | $27.37 Strike: $27.37 | $14,760,777.85 |
DisclosureSEC source: 0001225208-18-015222 · doc4.xml · derivative · entry 9 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 539,305 shares Expires 2020-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 02, 2018 Filed Nov 6, 2018 20:46 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 668,724 | $21.03 Strike: $21.03 | $14,063,265.72 |
DisclosureSEC source: 0001225208-18-015222 · doc4.xml · derivative · entry 8 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 668,724 shares Expires 2019-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 02, 2018 Filed Nov 6, 2018 20:46 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 548,885 | $32.23 Strike: $32.23 | $17,690,563.55 |
DisclosureSEC source: 0001225208-18-015222 · doc4.xml · derivative · entry 7 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 548,885 shares Expires 2019-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 02, 2018 Filed Nov 6, 2018 20:46 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionStock Appreciation Rights · Derivative | 483,092 | $34.59 Strike: $34.59 | $16,710,152.28 |
DisclosureSEC source: 0001225208-18-015222 · doc4.xml · derivative · entry 6 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 483,092 shares Expires 2020-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 02, 2018 Filed Nov 6, 2018 20:46 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 148,992 | $34.59 | $5,153,633.28 |
DisclosureSEC source: 0001225208-18-015222 · doc4.xml · nonDerivative · entry 4 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,760,958 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents the number of stock units received upon the exercise and conversion of previously granted stock appreciation rights (SARs), calculated by taking the change in our common stock price (20 trading day average ending on the exercise date (Election Price of $43.74)) less the grant price of the SAR plus accumulated dividends from the grant date, times the number of SARs exercised. This value is divided by the Election Price to determine the number of stock units. The stock units and accumulated dividend units will be settled in Pfizer common stock on the SAR original settlement date, the fifth anniversary of grant. Read SEC document |
| November 02, 2018 Filed Nov 6, 2018 20:46 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 212,200 | $32.23 | $6,839,206.00 |
DisclosureSEC source: 0001225208-18-015222 · doc4.xml · nonDerivative · entry 3 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,611,966 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents the number of stock units received upon the exercise and conversion of previously granted stock appreciation rights (SARs), calculated by taking the change in our common stock price (20 trading day average ending on the exercise date (Election Price of $43.74)) less the grant price of the SAR plus accumulated dividends from the grant date, times the number of SARs exercised. This value is divided by the Election Price to determine the number of stock units. The stock units and accumulated dividend units will be settled in Pfizer common stock on the SAR original settlement date, the fifth anniversary of grant. Read SEC document |
| November 02, 2018 Filed Nov 6, 2018 20:46 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 280,503 | $27.37 | $7,677,367.11 |
DisclosureSEC source: 0001225208-18-015222 · doc4.xml · nonDerivative · entry 2 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,399,766 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the number of stock units received upon the exercise and conversion of previously granted stock appreciation rights (SARs), calculated by taking the change in our common stock price (20 trading day average ending on the exercise date (Election Price of $43.74)) less the grant price of the SAR plus accumulated dividends from the grant date, times the number of SARs exercised. This value is divided by the Election Price to determine the number of stock units. The stock units and accumulated dividend units will be settled in Pfizer common stock on the SAR original settlement date, the seventh anniversary of grant. Read SEC document |
| November 02, 2018 Filed Nov 6, 2018 20:46 UTC | PFIZER INC PFE · Entity 2863 | Exercise / conversionCommon Stock | 458,506 | $21.03 | $9,642,381.18 |
DisclosureSEC source: 0001225208-18-015222 · doc4.xml · nonDerivative · entry 1 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,119,263 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents the number of stock units received upon the exercise and conversion of previously granted stock appreciation rights (SARs), calculated by taking the change in our common stock price (20 trading day average ending on the exercise date (Election Price of $43.74)) less the grant price of the SAR plus accumulated dividends from the grant date, times the number of SARs exercised. This value is divided by the Election Price to determine the number of stock units. The stock units and accumulated dividend units will be settled in Pfizer common stock on the SAR original settlement date, the seventh anniversary of grant. Read SEC document |
| October 02, 2018 Filed Oct 4, 2018 16:07 UTC | KIMBERLY CLARK CORP KMB · Entity 3103 | GrantRestricted Share Units · Derivative | 242.3468 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001225208-18-014398 · doc4.xml · derivative · entry 1 READ IAN C · CIK 0001372915 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,017.7081 Underlying: Common Stock · 242.3468 shares Expires not disclosed F1 · derivative.exercise_price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · price: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · derivative.exercise_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. F1 · derivative.expiration_date: Represents restricted share units, payable on a 1-for-1 basis, granted under the Kimberly-Clark Corporation 2011 Outside Directors' Compensation Plan. Additional restricted share units are accrued based on dividends paid on the Corporation's Common Stock. The restricted share units may not be sold or transferred until the reporting person ceases to be a member of the Corporation's Board of Directors. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 20:59 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 72,852 | $37.35 | $2,721,022.20 |
DisclosureSEC source: 0001225208-18-011785 · doc4.xml · nonDerivative · entry 25 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 659,440 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2018. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 20:59 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 61,325 | $37.34 | $2,289,875.50 |
DisclosureSEC source: 0001225208-18-011785 · doc4.xml · nonDerivative · entry 24 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 732,292 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2018. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 20:59 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 55,127 | $37.36 | $2,059,544.72 |
DisclosureSEC source: 0001225208-18-011785 · doc4.xml · nonDerivative · entry 23 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 793,617 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2018. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 20:59 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 46,564 | $37.37 | $1,740,096.68 |
DisclosureSEC source: 0001225208-18-011785 · doc4.xml · nonDerivative · entry 22 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 848,744 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2018. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 20:59 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 42,558 | $37.40 | $1,591,669.20 |
DisclosureSEC source: 0001225208-18-011785 · doc4.xml · nonDerivative · entry 21 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 895,308 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2018. Read SEC document |
| July 16, 2018 Filed Jul 17, 2018 20:59 UTC | PFIZER INC PFE · Entity 2863 | SaleCommon Stock | 34,099 | $37.30 | $1,271,892.70 |
DisclosureSEC source: 0001225208-18-011785 · doc4.xml · nonDerivative · entry 20 READ IAN C · CIK 0001372915 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 937,866 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 16, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.